Essential fatty acid distribution in the plasma and tissue phospholipids of patients with benign and malignant prostatic disease

British Journal of Cancer

Volumn 64, Issue 6, 1991, Pages 1157-1160

  Chaudry, A ^a   McClinton, S ^a   Moffat, L E F ^a   Wahle, K W J ^b  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOCOSAPENTAENOIC ACID; ESSENTIAL FATTY ACID; GAMMA LINOLENIC ACID; LINOLEIC ACID; OLEIC ACID; PHOSPHOLIPID; STEARIC ACID; UNCLASSIFIED DRUG;

ARACHIDONIC ACID METABOLISM; ARTICLE; BENIGN TUMOR; CLINICAL ARTICLE; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; HUMAN; LIPID ANALYSIS; MALE; MALIGNANT NEOPLASTIC DISEASE; PLASMA; PRIORITY JOURNAL; PROSTATE; PROSTATE TUMOR;

ARACHIDONIC ACID; FATTY ACIDS, ESSENTIAL; HUMAN; MALE; OLEIC ACID; OLEIC ACIDS; PHOSPHOLIPIDS; PROSTATIC DISEASES; PROSTATIC NEOPLASMS; STEARIC ACIDS;

EID: 0026356575     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1991.481     Document Type: Article

References (38)

1. APOSTOLOVE, K., BARKER, W., CATOVSKY, D., GOLDMAN, J. & MATUTES, E. (1985). Reduction in the stearic to oleic acid ratio in leukaemic cells - a possible chemical marker of malignancy. Blut, 50, 349.
2. BARTOLI, G.M., BARTOLI, S., GALEOTI, T. & BERTOLI, E. (1980). Superoxide dismutase content and microsomal lipid composition of tumours with different growth rates. Biochim. Biophys. Acta, 620, 205.
3. BEGIN, M.E., ELLS, G., DAS, U N. & HORROBIN, D.F. (1986). Differential killing of human carcinoma cells supplemented with n-3 and n-6 PUFA. J. Natl Cancer Inst., 77, 1053.
4. BIRKOFF, J.D. (1983). Natural history of benign prostatic hypertrophy. In Benign Prostatic Hypertrophy, Hinman, F. Jr (ed.), Springer-Verlag: New York.
5. BLAIR, A. & FRAUMENI, J.F. Jr (1978). Geographic pattern of prostatic cancer in the USA. J. Natl Cancer Inst., 61, 1379.
6. BURNS, C.P. & SPECTOR, A.A. (1987). Membrane fatty acid modification in tumour cells: a potential therapeutic adjunct. Lipids, 22, 178.
7. CARROLL, K.K. (1989). Fish oils and cancer. In Health Effects of Fish and Fish Oils, Chandra, R.K. (ed.), p. 395. ARTS Biomedical Publishers & Distributors: Newfoundland.
8. 2 alpha by the human prostate. Life Sci., 26, 29.
9. CHEESMAN, K.H., BURTON, G.W., INGOLD, K.U. & SLATER, T.F. (1984). Lipid peroxidation and lipid antioxidants in normal and tumour cells. Toxicol. Pathol, 12, 235.
10. COPLAND, S.A., MCHARDY, K.C., WAHLE, K.W.J. & HUTCHEON, A.W. (1990). Platelet stearic to oleic acid ratio is reduced in active malignant disease. Scott. Med. J., 35, 61.
11. COPLAND, S.A., MCHARDY, K.C., WAHLE, K.W.J. & HUTCHEON, A.W. (1991). Altered platelet membrane lipids in malignancy. Eur. J. Cancer (submitted).
12. DYEBERG, J., BANG, H.O. & HJORNE, N. (1975). Fatty acid composition of the plasma lipids in Greenland Eskimos. Am. J. Clin. Nutr., 28, 958.
13. EASTY, G.C. & EASTY, D.M. (1976). Prostaglandin and cancer. Cancer Treat. Rev., 3, 217.
14. FOLCH, J.M., LEES, M. & STANLEY, G.H.S. (1957). A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem., 226, 497.
15. GOODWIN, J.S. & CEUPPENS, J. (1983). Regulation of the immune response by prostaglandins. J. Clin. Immunol, 3, 295.
16. GOTTARD, S. (1986). Relevance of fatty acids and eicosanoids to clinical and preventive medicine. Prog. Lipid Res., 25, 1.
17. GRAHAM, S., HAUGHEY, B., MARSHALL, J. & 5 others (1983). Diet in the epidemiology of carcinomas of the prostate gland. J. Natl Cancer Inst., 70, 687.
18. HOLMAN, R.T. (1986). Nutritional and biochemical evidence of acyl interaction with respect to essential PUFA’s. Prog. Lipid Res., 25, 29.
19. HORROBIN, D.F. (1990). EFA, lipid peroxidation and cancer. In Omega-6 EFA, Pathophysiology and Roles in Clinical Medicine, Horrobin, D.F. (ed.), p 351. Wiley-Liss: USA.
20. HOWARD, S. (1986). The metabolism of n-3 and n-6 fatty acids and their oxygenation by platelet cyclooxygenase and lipoxygenase. Prog. Lipid Res., 25, 19.
21. HUBBARD, W.C., ALLEY, M.C., (1988). Profiles of prostaglandin biosynthesis in sixteen established cell lines derived from human lung, colon, prostate and ovarian tumours. Cancer Res., 48, 4770.
22. KITADA, S., HAY, E.F. & MEAD, J.F. (1980). A lipid mobilising factor in serum of tumour bearing mice. Lipids, 15, 168.
23. KLEIN, L.A. & STOFF, J.S. (1983). Prostaglandins and prostate. An hypothesis on the aetiology of BPH. Prostate, 4, 247.
24. KOLLMORGAN, G.M., KING, M.M., KOSANKE, S.D. & DO, C. (1983). Influence of dietary fat and indomethacin on the growth of transplantable mammary tumours in rats. Cancer Res., 43, 4714.
25. MASUNO, H., KAMASAKI, N. & OKUDA, H. (1981). Purification and characterisation of a lipolytic factor (Toxoharmone-L) from cell- free fluid of ascites sarcoma 180. Cancer Res., 41, 284.
26. NEOPTOLEMOS, J.P., HUSBAND, D., IMRAY, C., ROWLEY, S. & LAWSON, N. (1991). Arachidonic acid and docosahexaenoic acid are increased in human colorectal cancer. Gut, 32, 278.
27. NOZAWA, C.M. & APOSTOLOV, K. (1982). Increase in the saturation of Cl8 fatty acids induced by Coxsackie B6 virus in Vero cells. Virology, 120, 247.
28. PARKIN, D.M., LAARA, E. & MUIR, C.S. (1988). Estimates of the world wide frequency of sixteen major cancers in 1980. Int. J. Cancer, 41, 184.
29. POLLARD, M. & LUCKERT, P.H. (1986). Promotional effects of testosterone and high fat diet on the development of autochthonous prostate cancer in rats. Cancer Lett., 32, 223.
30. ROTKIN, I.D. (1977). Studies in the epidemiology of prostatic cancer: expanded sampling. Cancer Treat. Rep., 61, 173.
31. SCHUMAN, L.M., MANDEL, J., BLACKARD, C., BAUR, H., SCARLETT, J. & MCHUGH, R. (1977). Epidemiologic study of prostatic cancer: preliminary report. Cancer Treat. Rep., 61, 181.
32. SHENNEN, D.H. & BISHOP, O.S. (1974). Diet and mortality from malignant disease in 32 countries. West Indian Med. J., 23, 44.
33. SINCLAIR, H.M. (1979). The human nutritional advantages of plant foods over animal foods. Qual. Plant Fds. Hum. Nutr., 29, 7.
34. SINCLAIR, H.M. (1984). Essential fatty acids in perspective. Hum. Nutr. Clin. Nutr., 38, 245.
35. SNOWDON, D.A., PHILLIPS, R.L. & CHOI, W. (1984). Diet obesity and risk of fatal prostatic cancer. Am. J. Epidemiol., 120, 244.
36. STRAIN, A.J., EASTY, G.C. & NEVILLE, A.M. (1980). An experimental model of cachexia induced by a Xenografted human tumours. J. Natl. Cancer Inst., 64, 217.
37. WAHLE, K.W.J. (1983). EFA modification and membrane lipids. Proc. Nutr. Soc., 42, 273.
38. WOOD, C.B., HABIB, N.A., THOMPSON, A. & 5 others (1985). Increase of oleic acid in erythrocytes associated with malignancies. Br. Med. J., 291, 163.